Overview

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether combining mitomycin or porfiromycin with radiation therapy is more effective in treating patients with head and neck cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy plus either mitomycin or porfiromycin in treating patients with head and neck cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Treatments:
Mitomycin
Mitomycins
Porfiromycin